Found: 20
Select item for more details and to access through your institution.
Limited Sampling Strategy for Determination of Ibrutinib Plasma Exposure: Joint Analyses with Metabolite Data.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 2, p. 162, doi. 10.3390/ph14020162
- By:
- Publication type:
- Article
Safety of oral hydration after cisplatin infusion in an outpatient lung cancer unit.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Brentuximab vedotin in real life, a seven year experience in patients with refractory/relapsed CD30+ T cell lymphoma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2021, v. 27, n. 7, p. 1730, doi. 10.1177/1078155220968615
- By:
- Publication type:
- Article
Assessment of efficacy of postinfusion tubing flushing in reducing risk of cytotoxic contamination.
- Published in:
- American Journal of Health-System Pharmacy, 2020, v. 77, n. 22, p. 1866, doi. 10.1093/ajhp/zxaa357
- By:
- Publication type:
- Article
Investigating the clinical impact of dose‐banding for weekly paclitaxel in patients with breast cancer: A retrospective and monocentric study.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 7, p. 2283, doi. 10.1111/bcp.15702
- By:
- Publication type:
- Article
Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody-mediated disease.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 76, n. 5, p. 734, doi. 10.1111/bcp.12098
- By:
- Publication type:
- Article
Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cancer.
- Published in:
- Cancers, 2023, v. 15, n. 1, p. 313, doi. 10.3390/cancers15010313
- By:
- Publication type:
- Article
Retrospective, real‐life study of venetoclax plus azacitidine or low‐dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 6, p. 7175, doi. 10.1002/cam4.5459
- By:
- Publication type:
- Article
Identifying the reactive metabolites of tyrosine kinase inhibitors in a comprehensive approach: Implications for drug‐drug interactions and hepatotoxicity.
- Published in:
- Medicinal Research Reviews, 2019, v. 39, n. 6, p. 2105, doi. 10.1002/med.21577
- By:
- Publication type:
- Article
Association between clinically relevant toxicities of pazopanib and sunitinib and the use of weak CYP3A4 and P-gp inhibitors.
- Published in:
- European Journal of Clinical Pharmacology, 2020, v. 76, n. 4, p. 579, doi. 10.1007/s00228-020-02828-w
- By:
- Publication type:
- Article
Correction to: Formulae recently proposed to estimate renal glomerular filtration rate improve the prediction of carboplatin clearance.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
Severe toxicity of capecitabine in a patient with DPD deficiency after a safe FEC-100 experience: why we should test DPD deficiency in all patients before high-dose fluoropyrimidines.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2021, v. 87, n. 4, p. 579, doi. 10.1007/s00280-021-04233-1
- By:
- Publication type:
- Article
Formulae recently proposed to estimate renal glomerular filtration rate improve the prediction of carboplatin clearance.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Dexamethasone as a probe for docetaxel clearance.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2004, v. 54, n. 3, p. 265, doi. 10.1007/s00280-004-0823-0
- By:
- Publication type:
- Article
Easy and reliable maximum a posteriori Bayesian estimation of pharmacokinetic parameters with the open‐source R package mapbayr.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 10, p. 1208, doi. 10.1002/psp4.12689
- By:
- Publication type:
- Article
Dexamethasone as a probe for vinorelbine clearance.
- Published in:
- British Journal of Clinical Pharmacology, 2005, v. 60, n. 1, p. 45, doi. 10.1111/j.1365-2125.2005.02384.x
- By:
- Publication type:
- Article
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 6, p. 961, doi. 10.1038/s41416-024-02585-y
- By:
- Publication type:
- Article
Considering the Oral Bioavailability of Protein Kinase Inhibitors: Essential in Assessing the Extent of Drug–Drug Interaction and Improving Clinical Practice.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 1, p. 55, doi. 10.1007/s40262-022-01200-8
- By:
- Publication type:
- Article
Les thérapies orales en 2021 dans les leucémies aiguës myéloïdes : un travail d'équipe ! L'expérience toulousaine.
- Published in:
- Hematologie, 2021, v. 27, p. 36, doi. 10.1684/hma.2021.1632
- By:
- Publication type:
- Article
Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-019-14218-7
- By:
- Publication type:
- Article